OCWP
PLRX icon

Owl Creek Wealth Partners’s Pliant Therapeutics PLRX Stock Holding History

Owl Creek Wealth Partners’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,300
Closed -$2.9K – 1330
2026
Q1 		$2.9K Buy
+2,300
New +$2.9K ﹤0.01% 1082

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Owl Creek Wealth Partners's PLRX Position: Q2 2026 in Review

Owl Creek Wealth Partners sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 2,300 shares — an estimated $2.9K sold.

Owl Creek Wealth Partners first reported a position in PLRX in Q1 2026 and held it in 1 quarter. The position peaked at $2.9K in Q1 2026. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Owl Creek Wealth Partners reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Owl Creek Wealth Partners sold 2,300 Pliant Therapeutics shares in Q2 2026, an estimated $2.9K.
  • Owl Creek Wealth Partners first reported a position in Pliant Therapeutics in Q1 2026 and held it in 1 quarter.
  • Owl Creek Wealth Partners's Pliant Therapeutics position peaked at $2.9K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.